These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 6507374

  • 1. Aclacinomycin. Phase II evaluation in advanced squamous carcinoma of the head and neck.
    Kish JA, Al-Sarraf M.
    Am J Clin Oncol; 1984 Oct; 7(5):535-7. PubMed ID: 6507374
    [Abstract] [Full Text] [Related]

  • 2. Phase II trial of aclarubicin in epidermoid carcinoma of the head and neck.
    Carugati AA, Olivari AJ, Campos DM, Pradier R, Woolley PV.
    Cancer Treat Rep; 1986 Jun; 70(6):799-800. PubMed ID: 3524828
    [No Abstract] [Full Text] [Related]

  • 3. [Evaluation of aclacinomycin-A in head and neck cancer].
    Tsukuda M.
    Gan To Kagaku Ryoho; 1984 Nov; 11(11):2335-41. PubMed ID: 6594077
    [Abstract] [Full Text] [Related]

  • 4. A phase II trial of aclacinomycin-A in advanced squamous cell carcinoma of the head and neck.
    Eckenrode JL, Wheeler RH, Forastiere AA.
    Invest New Drugs; 1985 Nov; 3(4):389-92. PubMed ID: 3866756
    [Abstract] [Full Text] [Related]

  • 5. Bioreductive alkylating agent porfiromycin in combination with radiation therapy for the management of squamous cell carcinoma of the head and neck.
    Haffty BG, Son YH, Wilson LD, Papac R, Fischer D, Rockwell S, Sartorelli AC, Ross D, Sasaki CT, Fischer JJ.
    Radiat Oncol Investig; 1997 Nov; 5(5):235-45. PubMed ID: 9372546
    [Abstract] [Full Text] [Related]

  • 6. Role of paclitaxel, ifosfamide, and cisplatin in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.
    Shin DM, Glisson BS, Khuri FR, Hong WK, Lippman SM.
    Semin Oncol; 1998 Apr; 25(2 Suppl 4):40-4; discussion 45-8. PubMed ID: 9578061
    [Abstract] [Full Text] [Related]

  • 7. The evaluation of amifostine for mucosal protection in patients with advanced loco-regional squamous cell carcinomas of the head and neck (SCCHN) treated with concurrent weekly carboplatin, paclitaxel, and daily radiotherapy (RT).
    Suntharalingam M, Jaboin J, Taylor R, Wolf J, Banglore M, Van Echo D, Ord R.
    Semin Oncol; 2004 Dec; 31(6 Suppl 18):2-7. PubMed ID: 15726515
    [Abstract] [Full Text] [Related]

  • 8. Phase II trial of pyrazofurin in advanced head and neck cancer.
    Cheng E, Currie V, Wittes RE.
    Cancer Treat Rep; 1979 Dec; 63(11-12):2047-8. PubMed ID: 526937
    [No Abstract] [Full Text] [Related]

  • 9. Phase II study of methotrexate, vinblastine, doxorubicin, and cisplatin in patients with squamous cell carcinoma of the upper respiratory or alimentary passages of the head and neck.
    Okuno SH, Mailliard JA, Suman VJ, Edmonson JH, Creagan ET, Nair S, Levitt R, Kugler JW.
    Cancer; 2002 Apr 15; 94(8):2224-31. PubMed ID: 12001121
    [Abstract] [Full Text] [Related]

  • 10. Phase II evaluation of aclarubicin in lung cancer: a Southeastern Cancer Study Group Trial.
    Kramer BS, Birch R, Gockerman JP, Greco A, Prestridge K.
    Cancer Treat Rep; 1986 Jun 15; 70(6):803-4. PubMed ID: 3015404
    [No Abstract] [Full Text] [Related]

  • 11. Phase II study of induction chemotherapy with paclitaxel, ifosfamide, and carboplatin (TIC) for patients with locally advanced squamous cell carcinoma of the head and neck.
    Shin DM, Glisson BS, Khuri FR, Lippman SM, Ginsberg L, Diaz E, Papadimitrakopoulou V, Feng L, Francisco M, Garden A, Kies MS, Myers J, Clayman G, Hong WK.
    Cancer; 2002 Jul 15; 95(2):322-30. PubMed ID: 12124833
    [Abstract] [Full Text] [Related]

  • 12. Cisplatin, fluorouracil, and L-leucovorin induction chemotherapy for locally advanced head and neck cancer: the M.D. Anderson Cancer Center experience.
    Papadimitrakopoulou VA, Dimery IW, Lee JJ, Perez C, Hong WK, Lippman SM.
    Cancer J Sci Am; 1997 Jul 15; 3(2):92-9. PubMed ID: 9099459
    [Abstract] [Full Text] [Related]

  • 13. Aclacinomycin A. Phase II evaluation in bronchogenic squamous-cell carcinoma.
    Pazdur R, Samson MK, Baker LH.
    Am J Clin Oncol; 1987 Jun 15; 10(3):234-6. PubMed ID: 3473923
    [Abstract] [Full Text] [Related]

  • 14. Recent advances in paclitaxel-containing chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck.
    Shin DM, Glisson BS, Khuri FR, Ginsberg L, Lawhorn K, Hong WK, Lippman SM.
    Semin Oncol; 1997 Dec 15; 24(6 Suppl 19):S19-33-S19-37. PubMed ID: 9427263
    [Abstract] [Full Text] [Related]

  • 15. Phase II study of induction and adjuvant chemotherapy for squamous cell carcinoma of the head and neck. A long-term analysis for the Illinois Cancer Center.
    Athanasiadis I, Taylor S, Vokes EE, Pelzer HJ, Rademaker A, Mittal BB, Ganzenko N, Blough R, Lester EP, Kies MS.
    Cancer; 1997 Feb 01; 79(3):588-94. PubMed ID: 9028372
    [Abstract] [Full Text] [Related]

  • 16. Phase II ftorafur therapy in previously treated squamous cell cancers of the head and neck.
    Campbell M, Al-Sarraf M.
    Cancer Treat Rep; 1980 Feb 01; 64(4-5):713-5. PubMed ID: 6775805
    [Abstract] [Full Text] [Related]

  • 17. Phase I and pharmacokinetic study of tomudex combined with 5-fluorouracil plus levofolinic acid in advanced head and neck cancer and colorectal cancer.
    Caponigro F, Avallone A, McLeod H, Cartenì G, De Vita F, Casaretti R, Morsman J, Blackie R, Budillon A, De Lucia L, Gravina A, Catalano G, Comella P, Comella G.
    Clin Cancer Res; 1999 Dec 01; 5(12):3948-55. PubMed ID: 10632324
    [Abstract] [Full Text] [Related]

  • 18. Carboplatin in combination with raltitrexed in recurrent and metastatic head and neck squamous cell carcinoma: A multicentre phase II study of the Gruppo Oncologico Dell'Italia Meridionale (G.O.I.M.).
    Galetta D, Giotta F, Rosati G, Gebbia V, Manzione L, Di Bisceglie M, Borsellino N, Colucci G.
    Anticancer Res; 2005 Dec 01; 25(6C):4445-9. PubMed ID: 16334124
    [Abstract] [Full Text] [Related]

  • 19. A phase I/II study of paclitaxel plus cisplatin as first-line therapy for head and neck cancers: preliminary results.
    Hitt R, Hornedo J, Colomer R, Mendiola C, Brandariz A, Sevilla E, Alvarez-Vicent J, Cortés-Funes H.
    Semin Oncol; 1995 Dec 01; 22(6 Suppl 15):50-4. PubMed ID: 8643971
    [Abstract] [Full Text] [Related]

  • 20. Phase II trial of ICRF-187 in squamous cell carcinoma of the head and neck.
    Wheeler RH, Bricker LJ, Natale RB, Baker SR.
    Cancer Treat Rep; 1984 Feb 01; 68(2):427-8. PubMed ID: 6421483
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.